Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Sectors at Genopole

Innovative Biotherapies


Issues In Biotherapies: A Third Revolution In Therapeutics

The initial successes in clinical trials and the market arrival of the resulting therapeutic innovations for both rare and common diseases have laid a path for no less than a third revolution in medicine.
Genopole and its actors are able and willing to accompany this revolution and bring answers to the challenges within it. They are helping to build a biotherapies sector.
Consult our brochure >

Genopole: Biotherapies At The Heart Of Its History

Genopole is renowned for its scientific excellence in biotherapies. It is home to two French pioneers in the sector: Genethon for gene therapies in rare diseases, and I-Stem for the study of human pluripotent stem cells and their use in cell therapies. Indeed, Zolgensma, the first gene therapy to be approved for the childhood neuromuscular disease spinal muscular atrophy, was the fruit of research done at Genethon.

Genopole is a center of excellence in biotechnologies. It is the leader in Europe and a leader in the world for the development and production of advanced therapy medicinal products.

Genopole: A Fertile Ecosystem

The model developed by Genopole, that is, a biocluster uniting research, entrepreneurship, training and medicine, has shown its potential. An industrial biotherapies sector has come to be at Évry-Courcouronnes in partnership with national, European and global networks. Today, the value chain is complete, from R&D through to GMP production: initial and continuous training, academic research, tech- nology transfer accelerator for rare and common diseases, businesses providing R&D and services, a stem cell bank under construction and a gene therapy production facility.

>> More information about the innovative biotherapy sector, discover our dedicated brochure from the collection “Sectors at Genopole”

 

 

Share
With the support from